Acute phase serum cathepsin S level and cathepsin S/cystatin C ratio are the associated factors with cerebral infarction and their diagnostic value for cerebral infarction
© 2019 The Authors. Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia on behalf of Kaohsiung Medical University..
Cathepsin S plays an important role in the pathogenesis of several cardiovascular diseases; however, the relationship between serum cathepsin S and cerebral infarction (CI) is still unknown. This study aimed to investigate the relationship between acute phase serum cathepsin S level and cerebral infarction. A total of 202 stroke patients were enrolled into this study, and were divided into cerebral infarction (n = 140) group and non-cerebral infarction group (non-CI, n = 62). Fifty healthy individuals were recruited as the control group. Serum levels of cathepsin S and cystatin C were measured at days 1, 7, and 14 posthospitalization. Compared to the non-CI group, the CI group had significantly higher rates of hypertension, dyslipidemia, and smoking (all P < 0.05). The CI group had significantly higher cathepsin S levels and cathepsin S to cystatin C ratio (CatS/CysC) at both days 1 and 7 posthospitalization (both P < 0.05). Multivariate logistic regression analysis demonstrated that cathepsin S level (day 7) and CatS/CysC (days 1 and 7) were the associated factors with CI (all P < 0.05). Receiver operating characteristic (ROC) curve analysis revealed that the Area Under Curve (AUC) value of CatS-day7, CatS/CysC-day1, and CatS/CysC-day7 were 0.726 (95% CI: 0.652-0.800, P < 0.001), 0.641 (95% CI: 0.559-0.723, P = 0.001), and 0.721 (95% CI: 0.645-0.797, P = 0.039), respectively. Cathepsin S and CatS/CysC were associated with acute CI, and may have the potential to be the diagnostic biomarkers for CI. Our findings help to better understand the role of serum cathepsin S level in CI.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
---|---|
Enthalten in: |
The Kaohsiung journal of medical sciences - 35(2019), 2 vom: 01. Feb., Seite 95-101 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Ai-Wu [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acute-Phase Proteins |
---|
Anmerkungen: |
Date Completed 09.08.2019 Date Revised 09.08.2019 published: Print Citation Status MEDLINE |
---|
doi: |
10.1002/kjm2.12014 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM294718311 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM294718311 | ||
003 | DE-627 | ||
005 | 20231225082107.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/kjm2.12014 |2 doi | |
028 | 5 | 2 | |a pubmed24n0982.xml |
035 | |a (DE-627)NLM294718311 | ||
035 | |a (NLM)30848029 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Ai-Wu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Acute phase serum cathepsin S level and cathepsin S/cystatin C ratio are the associated factors with cerebral infarction and their diagnostic value for cerebral infarction |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.08.2019 | ||
500 | |a Date Revised 09.08.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2019 The Authors. Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia on behalf of Kaohsiung Medical University. | ||
520 | |a Cathepsin S plays an important role in the pathogenesis of several cardiovascular diseases; however, the relationship between serum cathepsin S and cerebral infarction (CI) is still unknown. This study aimed to investigate the relationship between acute phase serum cathepsin S level and cerebral infarction. A total of 202 stroke patients were enrolled into this study, and were divided into cerebral infarction (n = 140) group and non-cerebral infarction group (non-CI, n = 62). Fifty healthy individuals were recruited as the control group. Serum levels of cathepsin S and cystatin C were measured at days 1, 7, and 14 posthospitalization. Compared to the non-CI group, the CI group had significantly higher rates of hypertension, dyslipidemia, and smoking (all P < 0.05). The CI group had significantly higher cathepsin S levels and cathepsin S to cystatin C ratio (CatS/CysC) at both days 1 and 7 posthospitalization (both P < 0.05). Multivariate logistic regression analysis demonstrated that cathepsin S level (day 7) and CatS/CysC (days 1 and 7) were the associated factors with CI (all P < 0.05). Receiver operating characteristic (ROC) curve analysis revealed that the Area Under Curve (AUC) value of CatS-day7, CatS/CysC-day1, and CatS/CysC-day7 were 0.726 (95% CI: 0.652-0.800, P < 0.001), 0.641 (95% CI: 0.559-0.723, P = 0.001), and 0.721 (95% CI: 0.645-0.797, P = 0.039), respectively. Cathepsin S and CatS/CysC were associated with acute CI, and may have the potential to be the diagnostic biomarkers for CI. Our findings help to better understand the role of serum cathepsin S level in CI | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a cathepsin S | |
650 | 4 | |a cerebral infarction | |
650 | 4 | |a cystatin C | |
650 | 4 | |a ischemic stroke | |
650 | 7 | |a Acute-Phase Proteins |2 NLM | |
650 | 7 | |a Cystatin C |2 NLM | |
650 | 7 | |a Cathepsins |2 NLM | |
650 | 7 | |a EC 3.4.- |2 NLM | |
650 | 7 | |a cathepsin S |2 NLM | |
650 | 7 | |a EC 3.4.22.27 |2 NLM | |
700 | 1 | |a Han, Xin-Sheng |e verfasserin |4 aut | |
700 | 1 | |a Xu, Xiao-Tian |e verfasserin |4 aut | |
700 | 1 | |a Fang, Yan-Nan |e verfasserin |4 aut | |
700 | 1 | |a Chen, Hong-Bing |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Tao |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Kaohsiung journal of medical sciences |d 1996 |g 35(2019), 2 vom: 01. Feb., Seite 95-101 |w (DE-627)NLM086492993 |x 2410-8650 |7 nnns |
773 | 1 | 8 | |g volume:35 |g year:2019 |g number:2 |g day:01 |g month:02 |g pages:95-101 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/kjm2.12014 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 35 |j 2019 |e 2 |b 01 |c 02 |h 95-101 |